1. Use of progression-free survival as a valid endpoint in phase II cancer clinical trials

   • Maurie Markman

   Editor’s Commentary 26 April 2007 Pages: 159 - 160

2. Web alert

   • David S. Hong MD Division of Medicine, Phase I Program and Gl Medical Oncology, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. E-mail: dshong@mdanderson.org

   EditorialNotes 26 April 2007 Pages: 161 - 161

3. Recent advances in therapy for gastrointestinal stromal tumors

   • Robert G. Maki

   OriginalPaper 26 April 2007 Pages: 165 - 169

4. Pancreatic cancer: An update

   • Hedy Lee Kindler
   • Kathryn Bylow

   OriginalPaper 26 April 2007 Pages: 170 - 176

5. New developments in the treatment of gastrointestinal neuroendocrine tumors

   • Matthew H. Kulke

   OriginalPaper 26 April 2007 Pages: 177 - 183

6. Combined-modality therapy for esophageal and gastroesophageal junction cancers

   • Harry H. Yoon
   • Michael K. Gibson

   OriginalPaper 26 April 2007 Pages: 184 - 192

7. Shifting from clinical to biologic indicators of prognosis after resection of hepatic colorectal metastases

   • Timothy M. Pawlik
   • Michael A. Choti

   OriginalPaper 26 April 2007 Pages: 193 - 201

8. Rationale for, and approach to, studying modifiers of risk in persons with a genetic predisposition to colorectal cancer

   • Mark A. Jenkins
   • Melissa C. Southey
   • John L. Hopper

   OriginalPaper 26 April 2007 Pages: 202 - 207

9. Clinical trials in metastatic hormone-refractory prostate cancer: Improving docetaxel therapy by targeting bone-related growth factors

   • Daniel P. Petrylak

   Clinical Trials Report 26 April 2007 Pages: 211 - 212

10. The role of lymphadenectomy in patients undergoing radical cystectomy for bladder cancer

    • John P. Stein

    OriginalPaper 26 April 2007 Pages: 213 - 221

11. The role of high-intensity focused ultrasound in prostate cancer

    • John H. Lynch
    • Stacy Loeb

    OriginalPaper 26 April 2007 Pages: 222 - 225

12. Immunotherapy for prostate cancer

    • Lawrence Fong
    • Eric J. Small

    OriginalPaper 26 April 2007 Pages: 226 - 233